Medical Marijuana, Inc. Subsidiary HempMeds Names Renowned Cannabis Leader Raul Elizalde as CEO and Matheus Patelli as Managing Director of Brazil Operations - Seite 2

Nachrichtenquelle: globenewswire
19.11.2020, 15:00  |  126   |   |   

“Our goal is to continue to pioneer the medical cannabis market in Brazil, dedicating our efforts to providing high-quality products to consumers and bringing high-quality information to medical professionals,” HempMeds Brasil Managing Director Matheus Patelli said. “It is always important to remember that for this sector to continue to exist, impacting the lives of thousands of people who depend on CBD, we must be leaders in research, knowledge and providing expert education.”

About HempMeds 

Founded in 2012, HempMeds was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S. As a subsidiary of Medical Marijuana, Inc., HempMeds is the exclusive distributor for premium brands including Real Scientific Hemp Oil and Dixie Botanicals, and operates in all 50 states and 40 countries. HempMeds is the only company to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. To learn more, please visit www.hempmedspx.com.

About Medical Marijuana, Inc.

We are a company of firsts. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway and HempMeds; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Seite 2 von 3
Medical Marijuana Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Medical Marijuana, Inc. Subsidiary HempMeds Names Renowned Cannabis Leader Raul Elizalde as CEO and Matheus Patelli as Managing Director of Brazil Operations - Seite 2 Promotes International Executive Team to Further Capitalize on Growing CBD Market in Latin America SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) - via NewMediaWire - Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly …

Nachrichten des Autors

Titel
Titel
Titel
Titel